The Kenya Medical Research Institute (Kemri) is studying the potential of a vaginal ring in prevention of new HIV infection among adolescent and young women.
The research body is exploring the safety and tolerability of the ring which contains dapivirine, an antiretroviral drug, as well as a hormonal contraceptive, levonorgestrel. The pregnancy hormone will however only be infused in later studies, according to Kemri researchers.